Renal interstitial sclerosis in aging: Effects of enalapril and nifedipine

Journal of the American Society of Nephrology

Volumn 7, Issue 5, 1996, Pages 676-680

  Inserra, Felipe ^a,b   Romano, Luis A ^a,b   De Cavanagh, Elena M V ^a,b   Ercole, Liliana ^a,b   Ferder, León F ^a,b,c   Gomez, R Ariel ^a,b  

^a Institute of Nephrology   (Argentina)

^b Hebrew Argentine University   (Argentina)

^c NONE   (Argentina)

Author keywords

Aging; Angiotensin converting enzyme inhibitors (ACEI); Calcium channel blocking agent; Kidney; Renal interstitial sclerosis

Indexed keywords

ALPHA ACTIN; CREATININE; ENALAPRIL; NIFEDIPINE; RENIN; VIMENTIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FOOD INTAKE; KIDNEY FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCLEROSIS;

EID: 0030370126     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lemley KV, Kriz W: Anatomy of the interstitium. Kidney Int 1991;39:370-381.
2. Nath KA: Tubulo-interstitial disease as a major determinant of progressive renal injury. Am J Kidney Dis 1992; 20:1-17.
3. Yee J, Kuncio GS, Neilson EG: Tubulointerstitial injury following glomerulonephritis. Semin Nephrol 1991;11: 361-366.
4. Johnson RJ, Iidia H, Alpers CE, et al.: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex proliferation. J Clin Invest 1991;87: 847-858.
5. Romano LA, Ferder L, Inserra F, Ercole L, Gómez A: Intraglomerular expression of alpha-smooth muscle actin in aging mice. Hypertension (Dallas) 1994;23:889-893.
6. Inserra F, Romano L, Ercole L, de Cavanagh EMV, Pszenny V, Ferder L: Enalapril ameliorates interstitial fibrosis in the aging kidney. J Am Soc Nephrol 1993;4: 607.
7. Gómez RA, Chevalier RL, Sturgill VC, Johns DW, Peach MJ, Carey RM: Maturation of the intrarenal renin distribution in Wistar-Kyoto rats. J Hypertens 1986;4(Suppl 5):S31-S33.
8. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29: 577-580.
9. Lane HP, Steffes MW, Fioretto P, Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993;43:661-667.
10. Weibel ER. Stereological Methods. Practical Methods for Biological Morphometry. Vol II. London: Academic Press; 1979.
11. Tashiro A, Masuda T, Segawa I: Morphometric comparison of mitochondria and myofibrils of cardiomyocytes between hypertrophic and dilated cardiomyopathies. Virchows Arch A Pathol Anat 1990;416:473-478.
12. Ferder L, Inserra F, Romano L, Ercole L, Pzenny V: Decreased glomerulosclerosis in aging by angiotensin converting enzyme inhibitors. J Am Soc Nephrol 1994; 5:1147-1152.
13. Hayflick L: Recent advances in the cell biology of aging. Mech Ageing Dev 1980;14:59-79.
14. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural functional correlations in renal disease: Part II. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1970;1:631-640.
15. Mackensen-Haen S, Bohle A, Christensen J, Wehrmann M, Kendzuiorra H, Kokot F: The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol 1992;37:70-77.
16. Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T: The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats. J Hypertens 1993;11:1347-1355.
17. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75: 977-984.
18. Inserra F, Romano L, Ercole L, de Cavanagh EMV, Ferder L: Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging. Hypertension (Dallas) 1995;25:437-442.
19. Hayflick L: Recent advances in the cell biology of aging. Mech Ageing Dev 1980;14:59-79.
20. Harman D: The aging process. Proc Natl Acad Sci USA 1981;78:7124-7128.
21. Nath KA, Fischereder M, Hostetter TH: The role of oxidants in progressive renal injury. Kidney Int 1994; 45(Suppl 45):S111-S115.
22. Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J: Antioxidant effects of angiotensin-converting (ACE) inhibitors: Free radical and antioxidant scavenging are sulfhydryl-dependent, but lipid peroxidation is inhibited by both sulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol 1992;19:330-340.
23. Misik V, Tong Mak I, Stafford RE, Wegliki WB: Reactions of captopril and epicaptopril with transition metal ions and hydroxyl radicals: An EPR spectroscopy study. Free Radical Biol & Med 1993;15:611-619.
24. de Cavanagh EMV, Ercole L, Ferder L, Inserra F, Romano L, Pszenny V: Comparacion del efecto de inhibidores de la enzima convertidora de angiotensina (ACEIs) en la producciön de radicales libres en tejidos de ratón [Abstract]. Medicina (B Aires) 1993;53(Suppl II):51-52.
25. de Cavanagh EMV, Inserra F, Ferder L, Romano L, Ercole L, Fraga C: Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver. FEBS (Fed Eur Biochem Soc) Lett 1995;361:22-24.